Sanofi

Sanofi Intangible Assets

The Intangible Assets of Sanofi (SAN.PA) as of Nov 1, 2026 is 67.56 B EUR. In the previous year, Intangible Assets was 22.63 B EUR — a change of 198.56% (higher).

Intangible Assets

67.56 BEUR

YoY

198.56%

Last updated:

Intangible Assets of Sanofi is 2025 67.56 B EUR. Intangible Assets of Sanofi was 2024 22.63 B EUR. It decreases by 198.56% higher compared to the previous year.

The Sanofi Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
21.89 B EUR
Jan 1, 2019
16.51 B EUR
Jan 1, 2020
18.34 B EUR
Jan 1, 2021
21.41 B EUR
Jan 1, 2022
21.64 B EUR
Jan 1, 2023
24.32 B EUR
Jan 1, 2024
22.63 B EUR
Jan 1, 2025
67.56 B EUR
The Sanofi Intangible Assets history
YEARIntangible AssetsYoY
67.56 BEUR+198.56%
22.63 BEUR-6.95%
24.32 BEUR+12.38%
21.64 BEUR+1.09%
21.41 BEUR+16.72%
18.34 BEUR+11.10%
16.51 BEUR-24.58%
21.89 BEUR+67.35%
13.08 BEUR+20.23%
10.88 BEUR-9.54%
12.03 BEUR-17.31%
14.54 BEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

Intangible Assets of Sanofi is 67.56 B EUR in 2025.

Intangible Assets of Sanofi changed from 22.63 B EUR to 67.56 B EUR, representing a 198.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Sanofi since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Sanofi historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sanofi

All Key Metrics — Sanofi